Short interest in Vistagen Therapeutics Inc (NASDAQ:VTGN) decreased during the last reporting period, falling from 644.72K to 528.16K. This put 2.97% of the company's publicly available shares short.

Short interest for Vistagen Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Vistagen Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 256.92K shares traded per day, it would take 2.06 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.